Literature DB >> 8491004

Time course of restenosis during the first year after emergency coronary stenting.

A Kastrati1, A Schömig, R Dietz, F J Neumann, G Richardt.   

Abstract

BACKGROUND: Prevention of abrupt vessel closure after percutaneous transluminal coronary angioplasty (PTCA) represents one of the current indications for intracoronary stent implantation. After the procedure, the stented segment undergoes luminal changes that may lead to late restenosis. This study was undertaken to assess the time course of luminal changes during the first year after emergency placement of coronary stents. METHODS AND
RESULTS: Coronary stenting was indicated in patients with present or threatened vessel closure secondary to large dissections after PTCA. From June 1989 to May 1991, 82 patients who received Palmaz-Schatz stents and did not have early vessel occlusion after stenting were enrolled into a serial angiographic follow-up study. Coronary normal reference diameter and minimal luminal diameter were measured with an automated edge detection technique. Patients who underwent repeat PTCA for restenosis were excluded from further serial angiography. The restudy rate at 3, 6, and 12 months was 96%, 81%, and 90% of the eligible patients, respectively. The incidence of restenosis (defined as a diameter stenosis > or = 50%) was 22.0% at 3 months, 31.9% at 6 months, and 33.2% at 12 months. Minimal luminal diameter was increased from 0.66 +/- 0.32 mm before to 2.85 +/- 0.43 mm immediately after stenting. It was 0.46 +/- 0.31 mm smaller than the diameter of the maximally inflated balloon during the procedure. The reduction in minimal luminal diameter was 0.80 +/- 0.69 mm (p = 0.0001) for the first 3 months, 0.29 +/- 0.52 mm (p = 0.0001) between 3 and 6 months, and 0.13 +/- 0.32 mm (p = 0.01) for the last 6 months. The percentage of patients who presented a significant change in minimal luminal diameter (defined as > 0.60 mm) declined from 50.6% during the first 3 months and 18.9% between 3 and 6 months to 6.5% for the period between 6 and 12 months.
CONCLUSIONS: The incidence and the time course of restenosis after emergency coronary stenting are similar to that reported for conventional PTCA. Coronary lumen dimensions demonstrated a peak change at 3 months and remained mostly stable after the first 6 months.

Entities:  

Mesh:

Year:  1993        PMID: 8491004     DOI: 10.1161/01.cir.87.5.1498

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

Review 1.  Current understanding of coronary in-stent restenosis. Pathophysiology, clinical presentation, diagnostic work-up, and management.

Authors:  T M Schiele
Journal:  Z Kardiol       Date:  2005-11

2.  Treatment of intracranial stenoses using the Neuroform stent system: initial experience in five cases.

Authors:  Stefan Hähnel; Peter Ringleb; Marius Hartmann
Journal:  Neuroradiology       Date:  2006-05-24       Impact factor: 2.804

3.  Long term angiographic and clinical follow up in patients with stent implantation for symptomatic myocardial bridging.

Authors:  P K Haager; E R Schwarz; J vom Dahl; H G Klues; T Reffelmann; P Hanrath
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

4.  Changes in membrane glycoproteins of circulating platelets after coronary stent implantation.

Authors:  M Gawaz; F J Neumann; I Ott; A May; S Rüdiger; A Schömig
Journal:  Heart       Date:  1996-08       Impact factor: 5.994

5.  The creation of an antithrombotic surface by apyrase immobilization.

Authors:  Per H Nilsson; Anna E Engberg; Jennie Bäck; Lars Faxälv; Tomas L Lindahl; Bo Nilsson; Kristina N Ekdahl
Journal:  Biomaterials       Date:  2010-03-07       Impact factor: 12.479

Review 6.  Genetic risk factors and restenosis after percutaneous coronary interventions.

Authors:  A Kastrati; J Dirschinger; A Schömig
Journal:  Herz       Date:  2000-02       Impact factor: 1.443

7.  Intravascular ultrasound-guided emergency coronary Palmaz-Schatz stent placement without post-procedural systemic anticoagulation.

Authors:  R Blasini; F J Neumann; G Richardt; C Schmitt; R Paloncy; A Schömig
Journal:  Heart       Date:  1996-10       Impact factor: 5.994

8.  Serial angiographic and intravascular ultrasound evaluation to interrogate the presence of late "catch-up" phenomenon after Cypher® sirolimus-eluting stent implantation.

Authors:  Daniel Chamié; Alexandre Abizaid; J Ribamar Costa; Fausto Feres; J Fábio Almiro da Silva; Luiz Alberto P Mattos; Rodolfo Staico; Ricardo A Costa; Andréa Abizaid; Luiz Fernando L Tanajura; Amanda G M R Sousa; J Eduardo Sousa
Journal:  Int J Cardiovasc Imaging       Date:  2010-11-17       Impact factor: 2.357

9.  Trends in coronary artery revascularisation procedures in Western Australia, 1980-2001.

Authors:  M S T Hobbs; K A McCaul; M W Knuiman; J M Rankin; I Gilfillan
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

Review 10.  Stent restenosis and the use of drug-eluting stents in patients with diabetes mellitus.

Authors:  Ian J Sarembock
Journal:  Curr Diab Rep       Date:  2004-02       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.